• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑秃:对患者生活质量和疾病认知的影响:一项基于调查的研究

Alopecia Areata: Impact on Patients' Quality of Life and Disease Perception: A Survey-Based Study.

作者信息

Vestergaard Christian, Carrillo Daniel de la Rosa, Mandla Randeep, Frøstrup Anne Grete, Gren Susanne T, Vänni Petri, Asikainen Anna-Kaisa, Kofoed Kristian, Mørk Cato

机构信息

Department of Dermatology, Aarhus University hospital, Aarhus, Denmark.

Volvat Medical Centre, Oslo, Norway.

出版信息

Acta Derm Venereol. 2025 Jul 19;105:adv43318. doi: 10.2340/actadv.v105.43318.

DOI:10.2340/actadv.v105.43318
PMID:40682499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12305969/
Abstract

Alopecia areata significantly impacts patients' emotional and psychosocial well-being. This survey investigated patients' perspectives on disease severity and its impact on quality of life. The study evaluated whether disease assessment tools (Severity of Alopecia Tool, Dermatology Life Quality Index, and Patient Unique Stigmatization Holistic tool in dermatology) reflect patients' perceptions of their condition. The study was conducted as an anonymous social media survey in Norway and Denmark. The questionnaire was divided into 3 main sections: (i) demographics and disease characteristics; (ii) disease severity and QoL measures; and (iii) patient perception and psychosocial impact. A total of 360 individuals participated in the survey reporting alopecia areata as mild (15%), moderate (29%), or severe (58%). Some 61% reported alopecia areata to interfere with their daily or weekly activities. All disease assessment tools demonstrated an age-dependent pattern, where scores were highest in the youngest (< 30 years) responder group. The relationship between Dermatology Life Quality Index and Severity of Alopecia Tool scores was found to be weak (R-squared = 0.08). Similarly, the correlation between Dermatology Life Quality Index and self-reported disease severity was also weak (R-squared = 0.136). This study demonstrates that there is a clear need for the development of more comprehensive, validated, and patient-centred assessment tools that can accurately reflect the physical, emotional, psychological, and social challenges faced by individuals with alopecia areata.

摘要

斑秃对患者的情绪和社会心理健康有显著影响。这项调查研究了患者对疾病严重程度及其对生活质量影响的看法。该研究评估了疾病评估工具(斑秃严重程度工具、皮肤病生活质量指数和皮肤病患者独特污名化整体工具)是否反映了患者对自身病情的认知。该研究作为一项在挪威和丹麦进行的匿名社交媒体调查开展。问卷分为3个主要部分:(i)人口统计学和疾病特征;(ii)疾病严重程度和生活质量测量;以及(iii)患者认知和社会心理影响。共有360人参与了该调查,报告斑秃为轻度(15%)、中度(29%)或重度(58%)。约61%的人报告斑秃干扰了他们的日常或每周活动。所有疾病评估工具都呈现出年龄依赖模式,得分在最年轻(<30岁)的应答者组中最高。发现皮肤病生活质量指数与斑秃严重程度工具得分之间的关系较弱(决定系数=0.08)。同样,皮肤病生活质量指数与自我报告的疾病严重程度之间的相关性也较弱(决定系数=0.136)。这项研究表明,显然需要开发更全面、经过验证且以患者为中心的评估工具,以准确反映斑秃患者面临的身体、情绪、心理和社会挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/bda04b7c1d52/ActaDV-105-43318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/3f9ce8a7c77b/ActaDV-105-43318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/3bac953bda25/ActaDV-105-43318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/bda04b7c1d52/ActaDV-105-43318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/3f9ce8a7c77b/ActaDV-105-43318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/3bac953bda25/ActaDV-105-43318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/12305969/bda04b7c1d52/ActaDV-105-43318-g003.jpg

相似文献

1
Alopecia Areata: Impact on Patients' Quality of Life and Disease Perception: A Survey-Based Study.斑秃:对患者生活质量和疾病认知的影响:一项基于调查的研究
Acta Derm Venereol. 2025 Jul 19;105:adv43318. doi: 10.2340/actadv.v105.43318.
2
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.斑秃患者眉毛和睫毛受累情况及巴瑞替尼治疗反应的研究
Br J Dermatol. 2025 Apr 3. doi: 10.1093/bjd/ljaf088.
3
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
4
Treatments for alopecia areata: a network meta-analysis.斑秃治疗方法的网状荟萃分析。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2.
5
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.口服酪氨酸激酶3/肝细胞癌中表达的酪氨酸激酶家族激酶抑制剂芦可替尼24个月的疗效和安全性:斑秃的ALLEGRO IIb/III期和长期III期临床研究的综合分析
Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365.
6
Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors.基于人口统计学、临床、心理和社会因素,对斑秃亚组在生活质量受损方面进行识别与特征描述。
Psychol Health Med. 2025 Jul;30(6):1199-1211. doi: 10.1080/13548506.2024.2430857. Epub 2024 Nov 22.
7
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.

本文引用的文献

1
British Association of Dermatologists living guideline for managing people with alopecia areata 2024.英国皮肤科医师协会2024年斑秃患者管理实用指南
Br J Dermatol. 2025 Jan 24;192(2):190-205. doi: 10.1093/bjd/ljae385.
2
Comparison of self-estimated and clinician-measured SALT score in patients with alopecia areata: Patients with alopecia areata perceive themselves as more severe than dermatologists.
Indian J Dermatol Venereol Leprol. 2024 Jan 8:1-3. doi: 10.25259/IJDVL_439_2022.
3
Outreach Through Facebook: Do Patients With Atopic Dermatitis Provide Clinically Relevant Information When Recruited for Surveys on Social Media?通过脸书进行拓展:招募特应性皮炎患者参与社交媒体调查时,他们能提供具有临床相关性的信息吗?
JMIR Dermatol. 2023 Oct 5;6:e45226. doi: 10.2196/45226.
4
Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata.评估斑秃女性健康相关生活质量的测量工具的信度和效度。
Clin Exp Dermatol. 2023 Jun 5;48(6):681-684. doi: 10.1093/ced/llad066.
5
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.斑秃的负担:一项聚焦于生活质量、心理健康和工作效率的范围综述。
J Eur Acad Dermatol Venereol. 2023 Jan 27. doi: 10.1111/jdv.18926.
6
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness.银屑病在难治疗部位的管理挑战:治疗决策与有效性
Life (Basel). 2022 Dec 7;12(12):2050. doi: 10.3390/life12122050.
7
Patient Unique Stigmatization Holistic tool in dermatology (PUSH-D): Development and validation of a dermatology-specific stigmatization assessment tool.患者独特污名化整体工具(PUSH-D):皮肤病学特异性污名评估工具的开发与验证。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):443-450. doi: 10.1111/jdv.18641. Epub 2022 Oct 25.
8
Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.斑秃严重程度的界定:当前观点与多维框架
Dermatol Ther (Heidelb). 2022 Apr;12(4):825-834. doi: 10.1007/s13555-022-00711-3. Epub 2022 Mar 31.
9
Alopecia areata - Current understanding and management.斑秃——现有认识与治疗管理。
J Dtsch Dermatol Ges. 2022 Jan;20(1):59-90. doi: 10.1111/ddg.14689.
10
Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.斑秃患者生活质量的评估。欧洲皮肤病学会和性病学会生活质量和以患者为中心结局工作组的立场声明。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):1614-1621. doi: 10.1111/jdv.17370. Epub 2021 Jun 9.